Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A Phase 1 Study of HMPL-306 in Locally Advanced Solid Tumors with IDH mutations Ended

2024-516370-30-00 - Locally advanced or metastatic solid tumors - Cholang 3 2021-02-09
A Phase 1, Open-Label Study of the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-64264681 in Participants with Non-Hodgkin Lymphoma … Ended

2024-512686-13-00 non-Hodgkin lymphoma and chronic lymphocytic leukemia 3 2021-01-28
An Open-Label Phase I/II Study of Relatlimab (BMS-986016) with Nivolumab (BMS-936558) in Combination with 5-Azacytidine for Relapsed/Refract… Ended

2024-514948-89-00 Acute Myeloid Leukemia 9 2021-01-27
Study of DFF332 alone and in combination with Everolimus or Immuno-oncology therapies in patients with renal cell carcinoma and other select… Ended

2024-513379-41-00 Advanced, relapsed Clear Cell Renal Cell Carcinoma 1 2021-01-26
Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer (CERPASS) Ended

2024-512652-38-00 Cutaneous Squamous Cell Carcinoma 4 2021-01-25
Study of Cemiplimab in Patients with type of skin cancer Stage II to IV Cutaneous Squamous Cell Carcinoma Ended

2022-500811-37-00 Stage II to IV cutaneous squamous cell carcinoma 4 2021-01-19
Study to Investigate the Efficacy and Safety of CS1003 in Combination with Lenvatinib Compared to Placebo in Combination with Lenvatinib in … Ended

2024-517331-48-00 Unresectable advanced hepatocellular carcinoma 5 2021-01-18
Phase 1b/2 study of liposomal annamycin (l-annamycin) in patients with previously treated metastatic soft-tissue sarcomas (ANNA-SARC) Ended

2024-517678-12-00 METASTATIC SOFT-TISSUE SARCOMAS AFTER FAILURE ON AT LE 9 2021-01-14
Prophylactic nimodipine treatment for hearing preservation after vestibular schwannoma surgery: a randomized multi-center phase III trial (A… Ended

2024-518182-10-00 Acoustic schwannoma 5 2021-01-13
Phase I/II, First in Human, Dose Escalation Trial of TL-895 Monotherapy in Subjects with Relapsed/Refractory B-Cell Malignancies and Expansi… Ended

2024-516691-14-00 B Cell Malignancies and Chronic Lymphocytic Leukemia or 7 2021-01-05
A Phase 3 Global, Multicenter, Double-Blind Randomized Study of Carboplatin-Paclitaxel With INCMGA00012 or Placebo in Participants With Inop… Ended

2024-512331-72-00 Squamous Carcinoma of the Anal Canal 5 2020-12-22
Study of JNJ-74856665 in patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome Ended

2024-513918-35-00 Acute myeloid leukemia or Myelodysplastic syndrome 1 2020-12-22
A Study of Tiragolumab in Combination with Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin versus Pembrolizumab Plus Pemetrexed and C… Ended

2022-502031-20-00 Non-squamous non-small cell lung cancer (NSCLC) 10 2020-12-17
A study to test the efficacy and safety of Lazertinib in the treatment of patients with Locally Advanced or Metastatic Non-Small Cell Lung C… Ended

2024-514771-18-00 Adenocarcinoma of the lung (non-small cell lung cancer) 5 2020-12-15
A Study of Relatlimab in Combination with Nivolumab in Participants with Advanced Liver Cancer who have never been been Treated with Immuno-… Ended

2023-503519-13-00 Advanced Hepatocellular Carcinoma 4 2020-12-14
Study of Orally Administered CA-4948(IRAK4i) as a Monotherapy in patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome Ended

2024-513313-13-00 Acute Myelogenous Leukemia (AML) or higher-risk Myelody 9 2020-12-09
A study of Gilteritinib combined with chemotherapy to treat Children, Adolescents and Young Adults with Relapsed or Refractory Acute Myeloid… Ended

2024-512469-15-00 FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Dupli 9 2020-12-08
An open-label Phase 1 study of NEO-PTC-01 in patients with advanced or metastatic melanoma Ended

2023-508524-35-00 Metastatic melanoma 1 2020-12-01
TSRO-Ph2, Dostarlimab +CT vs Pembro +CT, 1L H2H efficacy comparison in Metastatic NSCLC pts. PERLA Ended

2023-505894-33-00 Lung Cancer, Non-Small Cell 4 2020-11-25
A phase I study evaluating safety and efficacy of Hepatic Intra- Arterial administration of ipilimumab in combination with Intra- venous niv… Ended

2023-506156-25-00 Advanced hepatocellular carcinoma 9 2020-11-13
A Phase 1b/2 Study of Abemaciclib Plus Chemotherapy and/or Chemoimmunotherapy in Pediatric and Young Adult Patients with Relapsed/Refractory… Ended

2023-506778-11-00 Relapsed/Refractory Solid Tumors 9 2020-11-11
A study to test Mirvetuximab Soravtansine (IMGN853) aganist doctor's choice of cancer medicines in women with advanced Epithelial Ovarian, P… Ended

2024-516111-25-00 Platinum-Resistant Advanced High-Grade Epithelial Ovari 5 2020-11-09
Efficacy of immunotherapy in combination with a drug in patients with advanced mucosal cancer of different locations that has progress. Ended

2023-510320-71-00 Squamous cell carcinoma of vulva/vagina 4 2020-10-27
A Phase 1 Open-label, Multicenter, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of HPN217 in Patients with Relaps… Ended

2024-515582-33-00 Relapsed/Refractory Multiple Myeloma (RRMM) 1 2020-10-26